Modification of a recombinant antigen results in improved diagnostic value for enzyme immunoassay detection of anti-Hepatitis C antibodies (904,12kb) . /N.V. Saveleva, O.E.Vankova, S.V. Klimashevskaya, E.M. Matveeva, A.N. Burkov, A.P. Obriadina //29th European  Congress  of Clinical Microbiology and Infectious Disease (ECCMID),Amsterdam, Netherlands 13-16 April 2019 – Ð 0789

Îïðåäåëåíèå àíòèòåë ê áåëêó F âèðóñà ãåïàòèòà Ñ ìåòîäîì èììóíîôåðìåíòíîãî àíàëèçà ñ èñïîëüçîâàíèåì ñèíòåòè÷åñêîãî ïåïòèäà. (6,60Mb) /Ëè÷íàÿ Å.Â., Êëèìàøåâñêàÿ Ñ.Â., Îáðÿäèíà À.Ï., Âåðáîâ Â.Í., Áåëîïîëüñêàÿ Ì.À., Ýñàóëåíêî Å.Â., Êàëèíèíà Î.Â.// Êëèíè÷åñêàÿ ëàáîðàòîðíàÿ äèàãíîñòèêà – 2018 - ¹63(3) – Ñ.183-186

Identification of HCV core regions responsible for false positive reaction  (447,66kb) ( Yuliya Zagryadskaya*1, Svetlana Klimashevskaya1,Elena Matveeva1, Anatoly Burkov1, Anna Obriadina1    1Rpc Diagnostic Systems  27th ECCMID Vienna, Austria 22-25 April 2017) P0844abstract  (153,02kb)

  
ÍÎÂÛÅ ÂÎÇÌÎÆÍÎÑÒÈ ÈÌÌÓÍÎÔÅÐÌÅÍÒÍÎÃÎ ÀÍÀËÈÇÀ ÄËß ÎÄÍÎÂÐÅÌÅÍÍÎÃÎ ÎÁÍÀÐÓÆÅÍÈß CORE-ÀÍÒÈÃÅÍÀ È ÀÍÒÈÒÅË Ê HCV  ÑÛÂÎÐÎÒÊÅ ÈËÈ ÏËÀÇÌÅ ÊÐÎÂÈ ×ÅËÎÂÅÊÀ_(193,09kb) ( ÌÀÒÂÅÅÂÀ E.Ì., ÊËÈÌÀØÅÂÑÊÀß Ñ.Â., ÂÀÍÜÊÎÂÀ O.Å., ÊÎÍÎÂÀËÅÍÀÊ È.À., ÓËÀÍÎÂÀ T.È., ÁÓÐÊΠA.Í., ÎÁÐßÄÈÍÀ A.Ï. Ðåìåäèóì Ïðèâîëæüå – 2015 - ¹4 (134) - Ñ.39)
 
Assessment of avidity index in blood donors samples with indeterminate anti-HCV reactivity   (173,44kb) (Y.E. Zagryadskaya, O.F. Fedorova, I.N. Sharipova, S.N. Klimashevskaya, A. P. Obriadina, N.M. Khodak, V.F. Puzyrev, A.N. Burkov,
T.I. Ulanova //25th European Congress of Clinical Microbiology and Infections Diseases, Copenhagen, Denmark. 25-28 April 2015- EV 1074)
 
HCV-specific IgG1 and IgG3 response to HCV infection (211,54kb)   (I.Konavalenak, E.Matveeva, T.Ulanova, A.Burkov, A.Obriadina;  24 th European Congress of Clinical Microbiology and Infections  Diseases, Barcelona. Spain. 10-13 May 2014)

Correlation between viral load and signal in combo-HCV-Ag/Ab enzyme immunoassay in human serum or plasma (29,08kb) (E.Matveeva, S.Klimashevskaya, I.Konavalenak, O.Vankova, T.Ulanova, A.Burkov, A.Obriadina;  24 th European Congress of Clinical Microbiology and Infections  Diseases, Barcelona. Spain. 10-13 May 2014
 
Influence of heterogeneity of amino acid sequence varying considerably on  immunoreactivity antigen region of HCV NS5 protein from position 2212 to 2313 (47,07kb) (G.Bochkova, T.Ulanova, V.Puzyrev, A.Burkov; 24 th European Congress of Clinical Microbiology and Infections  Diseases, Barcelona. Spain. 10-13 May 2014 – Ð1401  ) 
 
DIAGNOSTIC RELEVANCE OF SEQUENCE OF HETEROGENEITY OF THE HCV NS4 MOSAIC PROTEINS (83,67kb) (BOCHKOVA G., PUZYREV V., ZAGRYADSKAYA Y., OBRIADINA A., BURKOV A., ULANOVA T (European Congress of Clinical Microbiology and Infectious Diseases ECCMID), 27-30 April 2013, Berlin, Germany – Ð .2213)
 
 
THE EVALUATION OF THE NEW ELISA KIT EIA-ANTI -HCV-SPECTRUM-M INTENDED FOR SEPARATE DETECTION OF ANTI-IgM TO DIFFERENT HCV ANTIGENS (161.1Kb) (G.BOCHKOVA, S.FOMINA, V.PUZYREV, A.OBRIADINA, A.BURKOV and T.ULANOVA)
Journal of Viral Hepatitis, 2012, 19 (Suppl. 3), 5–30- Poster Sessions, P2
  
 
THE VALUE OF ANTI-HCV IgG AVIDITY INDEX AND ANTI-HCV IgG PROFILE FOR DISTINGUISHING OF ACUTE AND CHRONIC HEPATITIS Ñ VIRUS INFECTION350,27kb)  (G.BOCHKOVA , S.FOMINA, Ò.SHABALINA,  V.PUZYREV, A.OBRIADINA, A.BURKOV, T.ULANOVA  19-th International Symposium on Hepatitis C Virus and Related Viruses. – Veniñe, Italy  5-9 October, 2012. – P.264.)
 
THE EVALUATION OF THE ELISA KIT “DS-EIA-ANTI –HCV SPECTR-GM” AS SUPPLEMENTAL ASSAY FOR CONFIRMATION OF ANTI-HCV SCREENING POSITIVE RESULTS (22.7Kb) (G.BOCHKOVA, S.FOMINA, V.PUZYREV, A.OBRIADINA, A.BURKOV, T.ULANOVA 21th European Congress of Clinical Microbiology and Infection Diseases. – Milan, May 7-10, 2011. – P.2235.)
 
ÍÎÂÎÅ  Â  ÄÈÀÃÍÎÑÒÈÊÅ ÂÈÐÓÑÍÎÃÎ ÃÅÏÀÒÈÒÀ Ñ (331.3Kb) (À.Í.ÁÓÐÊÎÂ; Æ."Ðåìåäèóì Ïðèâîæüå", 2003, 9 (19): 23-24)
 
TWO IMMUNODOMINANT REGIONS WITHIN THE HEPATITIS C VIRUS NS3 PROTEIN (17.5Kb) (T.I.ULANOVA, G.R.TALEKER, J.C.CHANG, D.D.TUAN, W.M.TUN, E.N.LOPAREVA, A.N.BURKOV, H.A.FIELDS, Y.E.KHUDYAKOV , World Congress of Virology, Paris, July, 2002)
 
IDENTIFICATION AND IMMUNOLOGIC PROPERTIES OF ANTIGENIC REGIONS WITHIN THE HEPATITIS Ñ VIRUS NS3 PROTEIN (36.9Kb) (T.ULANOVA, G.TALEKAR, J.CHANG, D. DO TUAN, W.TUN, A.BURKOV, H.FIELDS, Y. KHUDYAKOV International Conference of Emerging Infections Diseases.- USA, Atlanta, 2002.- Ð.9.) 
 
ÕÀÐÀÊÒÅÐÈÑÒÈÊÀ ÏÀÍÅËÈ ÌÎÍÎÊËÎÍÀËÜÍÛÕ ÀÍÒÈÒÅË Ê ÐÅÊÎÌÁÈÍÀÍÒÍÎÌÓ ÁÅËÊÓ NS3 ÂÈÐÓÑÀ ÃÅÏÀÒÈÒÀ Ñ (230.3Kb) (À.Ã.ÀÁÄÓËÌÅÄÆÈÄÎÂÀ, Î.Â.ÌÀÑÀËÎÂÀ, Ñ.Í.ÀÒÀÍÀÄÇÅ, Ò.È.ÓËÀÍÎÂÀ, À.Í.ÁÓÐÊÎÂ, Þ.Å.ÕÓÄßÊÎÂ, Í.FIELDS, À.À.ÊÓÙ, : Æ. «Âîïðîñû âèðóñîëîãèè», 2002.- ¹1-Ñ.21-25)
 
ANTIGENIC VARIABILITY OF THE CORE PROTEIN OF THE HEPATITIS C VIRUS (13Kb) (G.R.TALEKER, T.D.DOL, T.ULANOVA, P.LIU, A.N.BURKOV, H.A.FIELDS, Y.E.KHUDYAKOV , 20th Annual Meeting, Madison. - USA, 2001. – P.102 (W22-6)
 
ANTIGENIC PROPERTY OF DIFFERENT SEQUENCE VARIANTS OF THE HEPATITIS C VIRUS NS3 PROTEINS(20.1Kb) (T.I.ULANOVA, D. DO TUAN, G.R.TALEKAR, H.A.FIELDS, Y.E.KHUDYAKOV , 20th Annual Meeting, Madison. - USA, 2001. – P.197 (Ð.26-8)
 
DETECTION OF NS3 AND NS4 PROTEINS IN HEPATOCYTES OF PATIENTS WITH CHRONIC HEPATITIS C (O.MASALOVA, E.LAKINA, A.ABDULMEDZHIDOVA, S.ATANADZE, T.ULANOVA, A.BURKOV, Y.KHUDYAKOV, H.FIELDS, A.KUSHCH, 10th international Symposium on viral hepatitis and liver disease, Atlanta, April, 2000, Antiviral Therapy 2000, 5 (Suppl.1):P.-C.127) (13.2Kb)
 
COMPOSITE RECOMBINANT ANTIGENS OF HEPATITIS C VIRUS (G.R.TALEKAR, H.C.THAI, T.ULANOVA, Y.DEVASH, Y.E.KHUDYAKOV, H.A.FIELDS, 10th international Symposium on viral hepatitis and liver disease, Atlanta, April, 2000, Antiviral Therapy 2000, 5 (Suppl.1):P.- C.7)(12.7Kb)
 
A NEW ANTI-HCV EIA BASED ON RECOMBINANT ANTIGENS DERIVED FROM DIFFERENT SEQUENCE VARIANTS OF HEPATITIS C VIRUS (23.5Kb) (T.ULANOVA, V.PUZYREV, L.KULIKOVA, G.BOCHKOVA, I.GOLUBEVA, A.OBRIADINA, A.BURKOV, 15th European Congress of clinical Microbiology and Infectious Diseases-Copenhagen, Denmark, 2005.- P.475.)
 
ÂËÈßÍÈÅ ÃÅÒÅÐÎÃÅÍÍÎÑÒÈ ÀÌÈÍÎÊÈÑËÎÒÍÎÉ ÏÎÑËÅÄÎÂÀÒÅËÜÍÎÑÒÈ ÍÀ ÈÌÌÓÍÎÐÅÀÊÒÈÂÍÎÑÒÜ ÊÎÌÏËÅÊÑÀ ÀÍÒÈÃÅÍÍÛÕ ÝÏÈÒÎÏÎÂ, ËÎÊÀËÈÇÎÂÀÍÍÎÃÎ Â ÏÐÅÄÅËÀÕ 1192-1456 ÀÌÈÍÎÊÈÑËÎÒ ÁÅËÊÀ NS3 ÂÈÐÓÑÀ ÃÅÏÀÒÈÒÀ Ñ (160.6Kb) (Ò.È.ÓËÀÍÎÂÀ, Â.Ô.ÏÓÇÛÐÅÂ, À.Í.ÁÓÐÊÎÂ, À.Ï.ÎÁÐßÄÈÍÀ, Æ. «Âîïðîñû âèðóñîëîãèè» -2006-¹1- Ñ.28-30)
 
ANTI-HCV PROFILE IN SERUM SPECIMENS FROM HCV INFECTED PATIENTS COINFECTED WITH OPPORTUNISTIC DISEASES (23Kb)  (G.B.BOCHKOVA, D.A.POLUSHINA, L.V.KULIKOVA, S.N.FOMINA, A.N.BURKOV, A.P.OBRIADINA, T.I.ULANOVA,  12 th International Symposium on Viral Hepatitis   and Liver Disease, Paris, 2006.-P.150)
 
ÎÏÐÅÄÅËÅÍÈÅ ÈÍÄÅÊÑÀ ÀÂÈÄÍÎÑÒÈ ÏÐÈ ÄÈÔÔÅÐÅÍÖÈÀËÜÍÎÉ ÄÈÀÃÍÎÑÒÈÊÅ ÎÑÒÐÎÉ, ÕÐÎÍÈ×ÅÑÊÎÉ È ÏÅÐÅÍÅÑÅÍÍÎÉ ÈÍÔÅÊÖÈÈ ÂÈÐÓÑÎÌ ÃÅÏÀÒÈÒÀ Ñ (26.5Kb) (C.Â.ÊËÈÌÀØÅÂÑÊÀß, Ã.Á.ÁÎ×ÊÎÂÀ, Ò.È.ÓËÀÍÎÂÀ, À.Í.ÁÓÐÊÎÂ, À.ÀÐÀÓÆÎ, Ñ.ÑÒÐÀÉÌÅÐ, Ë.ÒÎÁËÅÐ, Ì.ÁÓØ, Ã.ÔÈËÄÇ, À.Ï.ÎÁÐßÄÈÍÀ, Ìàòåðèàëû VI Ðîññèéñêîé íàó÷íî-ïðàêòè÷åñêîé êîíôåðåíöèè ñ ìåæäóíàðîäíûì ó÷àñòèåì «Ìîëåêóëÿðíàÿ äèàãíîñòèêà».- Ì.- 2007.-   Ñ. 252-253)
 
ÎÑÎÁÅÍÍÎÑÒÈ ÂÛßÂËÅÍÈß ÀÍÒÈ-HCV Ó ÄÅÒÅÉ Ñ ÏÅÐÈÍÀÒÀËÜÍÎÉ ÏÅÐÅÄÀ×ÅÉ ÂÈÐÓÑÀ ÃÅÏÀÒÈÒÀ Ñ (25Kb) (Í.Å.ÑÅÍßÃÈÍÀ, Ñ.Í.ÔÎÌÈÍÀ, Ì.Ã.ÍÈÊÈØÈÍÀ, Ã.Á.ÁÎ×ÊÎÂÀ, Â.Â.ÇÎÐÈÍ, À.Ï.ÎÁÐßÄÈÍÀ, À.Í.ÁÓÐÊÎÂ, Ò.È.ÓËÀÍÎÂÀ , Ìàòåðèàëû VII Ðîññèéñêîé íàó÷íî-ïðàêòè÷åñêîé êîíôåðåíöèè ñ ìåæäóíàðîäíûì ó÷àñòèåì «Âèðóñíûå ãåïàòèòû – ýïèäåìèîëîãèÿ, äèàãíîñòèêà, ëå÷åíèå è ïðîôèëàêòèêà» - 2007.-Ìîñêâà.- Ñ.67-68.)
 
DISTINGUISHING ACUTE FROM CHRONIC AND RESOLVED HEPATITIS C VIRUS (HCV) INFECTIONS BY MEASUREMENT OF ANTI-HCV IMMUNOGLOBULIN G AVIDITY INDEX(105Kb) (S.KLIMASHEVSKAYA, A.OBRIADINA, T.ULANOVA, G.BOCHKOVA, A.BURKOV, A.ARAUJO, SUSAN L.STRAMER, LESLIE H.TOBLER, MICHAEL P.BUSCH, HOWARD A.FIELDS, Journal of Clinical Microbiology, 2007, Vol. 45, N10.-P. 3400-3403, 14th International symposium on hepatitis C virus and related viruses, 9-13 September 2007, Glasgow, Scotland UK)
 
INFLUENCE OF THE HCV-CMV COINFECTION ON THE FORMATION OF ANTIBODY RESPONSE TO HCV AND CMV ANTIGENS (21.5Kb) (G.BOCHKOVA, S.FOMINA, V.PUZYREV, A.BURKOV, A.OBRIADINA, Ò.ULANOVA, 14th Internotional symposium on viral hepatitis C and related viruses, 9-13 September 2007, - Glasgow, Scotland UK)
 
THE DIAGNOSTICS OF THE PERINATALLY TRANSMITTED HCV INFECTION IN BABIS (23Kb) (S.N.FOMINA, N.E.SENYAGINA, M.G.NIKISHINA, G.B.BOCHKOVA, D.A.POLUSHINA, A.N.BURKOV, A.P.OBRIADINA, T.I.ULANOVA, 14th International symposium on viral hepatitis C and related viruses, 9-13 September 2007, Glasgow, Scotland UK)
 
ÎÏÐÅÄÅËÅÍÈÅ ÈÍÄÅÊÑÀ ÀÂÈÄÍÎÑÒÈ ÑÏÅÖÈÔÈ×ÅÑÊÈÕ ÀÍÒÈÒÅË ÄËß ÄÈÀÃÍÎÑÒÈÊÈ ÂÈÐÓÑÍÎÃÎ ÃÅÏÀÒÈÒÀ Ñ (982Kb) (Ñ.Â.ÊËÈÌÀØÅÂÑÊÀß, Ã.Á.ÁÎ×ÊÎÂÀ, Ò.È.ÓËÀÍÎÂÀ, À.Í.ÁÓÐÊÎÂ, À.Ï.ÎÁÐßÄÈÍÀ, Ã.ÔÈËÄÇ, Æ. «Ñïðàâî÷íèê çàâåäóþùåãî ÊÄË» - 2008.- Ñ.12-16.)
 
ÈÑÑËÅÄÎÂÀÍÈÅ ÈÌÌÓÍÎÃÅÍÍÎÑÒÈ ÊÎÂÀËÅÍÒÍÛÕ ÊÎÍÚÞÃÀÒΠÍÅÑÒÐÓÊÒÓÐÍÛÕ ÁÅËÊΠÂÈÐÓÑÀ ÃÅÏÀÒÈÒÀ Ñ Ñ ÈÌÌÓÍÎÌÀÊÑÎÌ (3.3Mb) (Î.Â.ÌÀÑÀËÎÂÀ, Å.È.ËÅÎÍÎÂÀ, À.Â.ÏÈ×ÓÃÈÍ, Ò.Ì.ÌÅËÜÍÈÊÎÂÀ, Ì.Ã.ÁÅËÈÊÎÂÀ-ÈÑÀÃÓËßÍÖ, Ò.È.ÓËÀÍÎÂÀ, À.Í.ÁÓÐÊÎÂ, Ð.È.ÀÒÀÓËËÀÕÀÍÎÂ, À.À.ÊÓÙ, Æ. «Èììóíîëîãèÿ».- 2008.-¹6.- Ñ.338-345)
 
THE DIAGNOSTIC VALUE OF THE DETECTION ANTI-HCV IgM TO DIFFERENT HEPATITIS C ANTIGENS (24Kb) (G.BOCHKOVA, D.POLUSHINA, C.FOMINA, N.SENYAGINA, V.PUZYREV, A.BURKOV, T.ULANOVA, 15th International Symposium on Hepatitis C Virus and Related Viruses.- San Antonio,USA -October 3-8, 2008)
 
SIMULTANEOUS DETECTION OF ANTIBODIES TO HEPATITIS C VIRUS PROTEINS USING THE LUMINEX SYSTEM TO DISTINGUISH ACUTE FROM CHRONIC INFECTION (23Kb) (A.ARAUJO, I.ASTRAKHANTSEVA, Z.DIMITROVA, T.ULANOVA, A.OBRIADINA, H.FIELDS, Emerging Technologies of Medical Importance for the Diagnosis of Infectious Diseases and the Detection of Pathogenic Microbes - Beijing, China, April 6-10, 2008)
 
SERUM IgM ANTIBODIES TO DIFFERENT HCV ANTIGENS IN INCIDENT, CHRONIC AND RESOLVED INFECTION (23Kb) (I.ASTRAKHANTSEVA, A.ARAUJO, A.OBRIADINA, S.KAMILLI, 15th International Symposium on Hepatitis C Virus and Related Viruses - San Antonio, TX, USA, October 5-9, 2008)
 
ÄÍÊ-ÈÌÌÓÍÈÇÀÖÈß ÏËÀÇÌÈÄÎÉ, ÑÎÄÅÐÆÀÙÅÉ ÃÅÍ ÁÅËÊÀ NS5A ÂÈÐÓÑÀ ÃÅÏÀÒÈÒÀ Ñ, ÈÍÄÓÖÈÐÓÅÒ ÝÔÔÅÊÒÈÂÍÛÉ ÊËÅÒÎ×ÍÛÉ ÈÌÌÓÍÍÛÉ ÎÒÂÅÒ (1.3Mb) (Î.Â.ÌÀÑÀËÎÂÀ, Å.È.ËÅÑÍÎÂÀ, Â.Â.ÃÐÀÁÎÂÅÖÊÈÉ, Î.À.ÑÌÈÐÍÎÂÀ, Ò.È.ÓËÀÍÎÂÀ, À.Í.ÁÓÐÊÎÂ, À.Â.ÈÂÀÍÎÂ, À.Ä.ÇÀÁÅÐÅÆÍÛÉ, Ð.È.ÀÒÀÓËËÀÕÀÍÎÂ, À.À.ÊÓÙ, Æ. «Ìîëåêóëÿðíàÿ áèîëîãèÿ» – 2010.- Ò. 44- ¹2- Ñ.275–283)
 
THE EVALUATION OF THE ELISA KIT "ElA-anti-HCV" WITH NEW RECOMBINANT ANTIGENS (23.5Kb) (G.BOCHKOVA,V.PUZYREV, A.OBRIADINA, A.BURKOV, T.ULANOVA, 20th European Congress of Clinical Microbiology and Infectious Diseases, Viena, Austria, 10-13 April, 2010.-Ð.1084)
 
PATIENTS PCR AND HEPATITIS C AVIDITY(22.5Kb) (S.KLIMASHEVSKAYA, T.ULANOVA, A.BURKOV, H.FIELDS, A.OBRIADINA , 20th European Congress of Clinical Microbiology and infectious Diseases.- Vienna.- Austria -10-13 April, 2010.-Ð.1113)
 
SIMULTANEOUS DETECTION OF SPECIFIC IgG RESPONSES TO STRUCTURAL AND NON-STRUCTURAL HCV ANTIGENS TO IDENTIFY ACUTE HCV INFECTION (80Kb) (A.C.ARAUJO, I.V.ASTRAKHANTSEVA, T.I.ULANOVA, A.P.OBRIADINA, H.A.FIELDS, S.KAMILI)
 
   
DIAGNOSTIC RELEVANCE OF THE HEPATITIS C VIRUS CORE AND NS3 PROTEINS(50Kb)
(Y.KHUDYAKOV, T.ULANOVA, G.TALEKAR, D.DO TUAN, A.BURKOV, H.FIELDS; 8th International Symposium on hepatitis C virus & Related viruses. - USA, 2002.-Ð. 297.)
 
CHARACTERIZATION OF MONOCLONAL ANTIBODIES AND EPITOPE MAPPING OF THE NS4 PROTEIN OF HEPATITIS C VIRUS( 708.9Kb)
 
 
G.BOCHKOVA, S.FOMINA, V.PUZYREV, A.OBRIADINA, A.BURKOV and T.ULANOVA Journal of Viral Hepatitis, 2012, 19 (Suppl. 3), 5–30- Poster Sessions, P2
 
THE EVALUATION OF THE NEW ELISA KIT EIA-ANTI -HCV-SPECTRUM-M INTENDED FOR SEPARATE DETECTION OF ANTI-IgM TO DIFFERENT HCV ANTIGENS (161.1Kb)